| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 394.40M | 437.70M | 496.20M | 478.10M | 442.40M |
| Gross Profit | 128.40M | 133.00M | 135.90M | 127.20M | 103.60M |
| EBITDA | 63.80M | 112.40M | 24.40M | 64.90M | 21.80M |
| Net Income | -4.40M | 46.30M | -62.40M | -11.10M | -27.80M |
Balance Sheet | |||||
| Total Assets | 514.00M | 511.30M | 558.20M | 609.00M | 624.90M |
| Cash, Cash Equivalents and Short-Term Investments | 59.50M | 86.20M | 77.50M | 53.60M | 68.00M |
| Total Debt | 202.90M | 194.10M | 279.00M | 242.10M | 253.50M |
| Total Liabilities | 326.70M | 321.00M | 409.60M | 390.70M | 414.30M |
| Stockholders Equity | 186.80M | 189.90M | 148.00M | 217.80M | 209.90M |
Cash Flow | |||||
| Free Cash Flow | 35.80M | 17.60M | 6.60M | 11.50M | 25.30M |
| Operating Cash Flow | 60.80M | 49.30M | 37.80M | 44.50M | 48.90M |
| Investing Cash Flow | -28.50M | 79.70M | -4.70M | -15.80M | -1.90M |
| Financing Cash Flow | -29.50M | -131.60M | -27.40M | -40.10M | -26.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £2.97B | 19.41 | 16.69% | 1.27% | 0.84% | -62.73% | |
75 Outperform | £1.49B | 17.83 | 12.93% | 2.89% | 3.29% | -8.76% | |
71 Outperform | £3.98B | 13.49 | 23.73% | 1.80% | 9.97% | -15.46% | |
71 Outperform | £262.48M | 4.85 | 11.00% | 4.85% | 25.24% | 19.81% | |
64 Neutral | £72.22M | 85.60 | 4.97% | 2.25% | -15.64% | -22.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | £251.82M | -42.97 | -2.37% | ― | -12.37% | ― |